Drugs / Iron Sulfate
Iron Sulfate
Trials 23
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02957643 | Nov 2016 → Sep 2017 | deficiency anemia | Hippocration General Hospital | Completed | No outcome recorded |
| Phase 24 trials · 1 met primary | ||||||
| Phase 2 | NCT02908581 | Jun 2016 → Apr 2017 | heavy metal poisoning | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Completed | No outcome recorded |
| Phase 2 | NCT01949467 | Feb 2014 → Dec 2017 | hemochromatosis type 4 | Rennes University Hospital | Completed | No outcome recorded |
| Phase 2 | NCT00964496 | Nov 2004 → Nov 2007 | angiodysplasia, gastric antral vascular ectasia | Shanghai Jiao Tong University School of Medicine | Completed | Met primary |
| Phase 2 | NCT00386074 | May → Dec 2004 | anemia | Wageningen University | Completed | No outcome recorded |
| Phase 36 trials · 1 met primary · 1 missed | ||||||
| Phase 3 | NCT04691843 | Feb 2021 → Aug 2024 | iron deficiency anemia | Ann & Robert H Lurie Children's Hospital of Chicago | Completed | No outcome recorded |
| Phase 3 | NCT02631980 | Oct 2015 → Oct 2016 | anemia | University Hospital, Geneva | Completed | No outcome recorded |
| Phase 3 | NCT00255437 | Jun 2004 → Nov 2006 | anemia | AMAG Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00255424 | May 2004 → Aug 2006 | anemia | AMAG Pharmaceuticals, Inc. | Completed | Met primary |
| Phase 3 | NCT00255385 | Apr 2002 → Apr 2004 | diarrheal disease, pneumonia | Johns Hopkins Bloomberg School of Public Health | Completed | Mixed |
| Phase 3 | NCT00109551 | Oct 2001 → Jan 2006 | — | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | Missed primary |
| Phase 44 trials | ||||||
| Phase 4 | NCT06550362 | Dec 2026 → May 2027 expected | iron deficiency anemia | Loma Linda University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06427200 | Jul 2024 → Jul 2027 expected | symptomatic heart failure | Cairo University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT02774057 | Mar 2016 → Jul 2017 | inflammatory bowel disease, iron deficiency anemia | American University of Beirut Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT00558454 | Mar 2004 → Jun 2008 | anemia, disorder of iron metabolism and transport, disruptive behavior disorder, perceptual disorders | Umeå University | Completed | No outcome recorded |
| Phase not applicable8 trials | ||||||
| — | NCT06875947 | May 2025 → Apr 2026 overdue | iron deficiency anemia, pregnancy disorder | Padjadjaran University | Active not recruiting | No outcome recorded |
| — | NCT03073590 | Jan 2016 → Jun 2017 | anemia | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| — | NCT01823029 | Nov 2012 → Jul 2013 | Crohn disease | Jinling Hospital, China | Completed | No outcome recorded |
| — | NCT01069198 | Oct 2009 → Oct 2010 | visceral leishmaniasis | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| — | NCT00394862 | Jan → Jun 2006 | neural tube defect | Emory University | Completed | No outcome recorded |
| — | NCT01507792 | Jan 2002 → Jan 2011 | bronchial disorder, disorder of iron metabolism and transport, laryngeal disorder | University of Turin, Italy | Completed | No outcome recorded |
| — | NCT00284700 | Dec 1997 → May 2001 | Helicobacter pylori infectious disease, iron deficiency anemia | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| — | NCT00497471 | Feb 1995 → Jul 1999 | Plasmodium falciparum malaria, iron deficiency anemia | Hospital Clinic of Barcelona | Terminated | No outcome recorded |
| Comparator or background therapy25 trials | ||||||
| Phase 0 | NCT07577817 Background | Jun → Oct 2026 expected | anemia, chronic kidney disease, disorder of iron metabolism and transport | Cajal Therapeutics Inc. | Recruiting | No outcome recorded |
| Phase 2 | NCT02564796 Comparator | Nov 2016 → Jun 2020 | anemia, congenital heart disease | University of California, San Diego | Terminated | No outcome recorded |
| Phase 2 | NCT01490944 Background | Jan → Nov 2012 | anemia | Indian Council of Medical Research | Unknown | No outcome recorded |
| Phase 3 | NCT04464850 Comparator | Jul 2020 → Jan 2021 | iron deficiency anemia | Chiang Mai University | Unknown | No outcome recorded |
| Phase 3 | NCT04189367 Background | Jun 2020 → Jul 2022 | burning mouth syndrome | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT02278341 Background | Nov 2014 → Jun 2017 | anemia, end stage renal failure | Astellas Pharma Europe B.V. | Completed | Met primary |
| Phase 3 | NCT01787526 Comparator | Jun 2014 → Aug 2016 | iron deficiency anemia | Medical University of Graz | Completed | Met primary |
| Phase 3 | NCT01820052 Comparator | Apr 2013 → May 2015 | fibromyalgia | Sanjay Gandhi Postgraduate Institute of Medical Sciences | Completed | No outcome recorded |
| Phase 3 | NCT01553123 Background | Apr 2012 → Nov 2013 | leiomyoma | Watson Pharmaceuticals | Withdrawn | No outcome recorded |
| Phase 3 | NCT01414374 Comparator | Jan → Dec 2012 | iron deficiency anemia | Casa Espirita Terra de Ismael | Completed | No outcome recorded |
| Phase 3 | NCT01145638 Comparator | Oct 2010 → Apr 2014 | chemotherapy-induced toxicity, neoplasm | Pharmacosmos A/S | Completed | Met primary |
| Phase 3 | NCT01102413 Comparator | Apr 2010 → Jun 2014 | chronic kidney disease, iron deficiency anemia | Pharmacosmos A/S | Completed | No outcome recorded |
| Phase 3 | NCT01017614 Comparator | Oct 2009 → Jul 2012 | inflammatory bowel disease | Pharmacosmos A/S | Completed | No outcome recorded |
| Phase 3 | NCT00755755 Background | Oct 2008 → Mar 2010 | leiomyoma | PregLem SA | Completed | Met primary |
| Phase 4 | NCT07758335 Comparator | Jul 2025 → Mar 2027 expected | ulcerative colitis | National Hepatology & Tropical Medicine Research Institute | Recruiting | No outcome recorded |
| Phase 4 | NCT04497012 Comparator | Nov 2020 → Mar 2025 | anemia of prematurity | University of South Florida | Unknown | No outcome recorded |
| Phase 4 | NCT04391998 Comparator | May 2020 → Aug 2021 | anemia | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT03542825 Comparator | Jan → Sep 2018 | iron deficiency anemia | South Valley University | Completed | No outcome recorded |
| Phase 4 | NCT02487719 Comparator | Jun 2015 → Jun 2016 | iron deficiency anemia, pregnancy disorder | University of Zurich | Unknown | No outcome recorded |
| — | NCT05678647 Comparator | Jan 2023 → Mar 2026 | — | Uppsala University Hospital | Completed | No outcome recorded |
| — | NCT04101461 Comparator | Oct 2019 → Apr 2022 | anemia | Assiut University | Completed | No outcome recorded |
| — | NCT02949765 Comparator | Dec 2015 → Jun 2017 | celiac disease, disorder of iron metabolism and transport | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Unknown | No outcome recorded |
| — | NCT01265680 Background | Feb → Nov 2012 | — | Cardiochirurgia E.H. | Completed | No outcome recorded |
| — | NCT00269542 Background | Feb 2002 → Mar 2003 | diarrheal disease, pneumonia | Society for Applied Studies | Completed | No outcome recorded |
| — | NCT00895453 Comparator | May 2000 → Feb 2006 | vulvovaginal candidiasis | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 16 cited values
Every value below carries the sentence it was read from. 52 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iron sulfate | “Patients were randomized in a 2:1 ratio to either intravenous iron isomaltoside or oral iron sulfate.” PMID 26927900 ↗ Apr 20167“Iron Sulfate will be given in liquid form via nasal or oral gastric tube with feeds.” NCT04497012 ↗ |
| Known as | Electrolytic Iron | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00386074 ↗ |
| Known as | Ferrous fumarate component of lo minastrin fe | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200640 ↗ |
| Known as | Ferrous fumarate component of minastrin 24 fe | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200640 ↗ |
| Known as | Ferrous fumarate component of norquest fe | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200640 ↗ |
| Known as | ferrum metallicum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00895453 ↗ |
| Known as | Fersaday | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200640 ↗ |
| Known as | Fersamal | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200640 ↗ |
| Known as | Fumafer | “All patients will receive a tablet of 66mg of iron, in the form of iron fumarate (Fumafer®) with 50 ml water.” NCT01949467 ↗ |
| Known as | Iron | “the intervention will consist of the twice weekly provision of iron/folate supplements to female workers, and the enhanced BCC program, as described above.” NCT03073590 ↗30“Nutritional supplement: vitamin B12, folic acid, iron, zinc, vitamin B complex depending on the hematic deficiency, for 12 weeks” NCT04189367 ↗ “80.000 UI of Human Recombinant Erythropoietin and intravenous iron at time of arrival at the hospital” NCT01265680 ↗ “different levels of folic acid, Vitamin B12, iron and zinc” NCT00394862 ↗ “iron 30 mg” NCT07758335 ↗ |
| Known as | iron (II)fumarate | “176 healthy male and female blood donors with iron deficiency (ferritin ≤30 ng/mL) were randomized to either a single dose of IV ferric carboxymaltose (1000 mg, n = 86) or oral...” PMID 30981629 ↗ Mar 2019 |
| Known as | iron fumarate | “1 tablet, three times a day, of iron fumarate will be prescribed for 24 weeks of study period.” NCT04464850 ↗2“oral iron supplementation (10 g iron fumarate, 100 capsules, n = 90).” PMID 32380660 ↗ May 2020 |
| Known as | Iron Sulphate | “Patients will receive iron sulphate, 500 mg, BID, plus orange juice, for 6 weeks.” NCT01414374 ↗5“Iron Sulphate 150 mg once daily” NCT03542825 ↗ |
| Modality | Other / unclassified | “micronutrients (especially of zinc and iron)” PMID 20730057 ↗ Aug 2010 |
| Modality | Small molecule | — CHEMBL1200640 ↗ |
| Route | Oral | “children consuming MN milk” PMID 20730057 ↗ Aug 2010 |